Stigma
An Emergency Medicine Guide to Medication for Opioid Use Disorder
Session originally hosted April 2024.
Using buprenorphine in the emergency department (ED) to treat opioid use disorder (OUD) is both safe and highly effective, yet certain barriers exist that make it underutilized and difficult to access. One of the most challenging barriers is stigma, which is found throughout the care process and targets both patients and medication.
In this training, we will focus on identifying the origins of stigma among ED clinicians, staff, and patients. We will explore de-stigmatizing language and behaviors while practicing how to improve interactions with patients and colleagues in the ED.
At the conclusion of this training, learners should be able to:
- Identify origins of clinician related stigma.
- Detect stigma among patients related to medication for opioid use disorder.
- Demonstrate de-stigmatizing language and behaviors.
- Recognize and critique stigmatizing behaviors among colleagues.
1 CME Credit. These opportunities also count toward the DEA eight-hour training requirement on the treatment and management of patients with opioid or other substance use disorders.
Presenters: Joseph Miller, MD & Dominic Borgialli, MD
Original Release Date: April 18, 2024
Termination Date: April 17, 2027
Accreditation Statement: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of MyMichigan Health and Michigan Health & Hospital Association. MyMichigan Health is accredited by the Michigan State Medical Society to provide continuing medical education for physicians. MyMichigan Health designates this activity for a maximum of 1 AMA PRA Category I Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure Statement: Planners, faculty, and others in control of content (either individually or as a group) have no relevant financial relationships with ineligible companies.
Note: Continuing medical education (CME) credits were pursued by the MHA Keystone Center, Please reach out to keystone@mha.org with questions.
